The Rawls College's STEM MBA program welcomed Lota Zoth, CPA, to speak during the STEM MBA Speaker Series, sponsored by the Texas Tech Alumni Association. Approximately 25 STEM MBA students and several Rawls faculty and staff members attended Zoth's presentation, where she offered career advice and detailed her vast experience in STEM-related fields.
Throughout the presentation, Zoth, who is a 1982 Texas Tech Accounting alumna, spoke about the core competencies that she felt were pivotal for students who want to succeed in the STEM industry. She later opened the floor to a question-and-answer session for students to learn more about her path to success.
"For me, whenever I was at Texas Tech, it was very rare for me to talk to anyone who wasn't an accountant. By them hearing from someone who has STEM experience, I feel that I was able to help students think about things differently as they go and start their careers," Zoth said. "I wanted to share some of my insight and wisdom that I've learned throughout my career, which I hope will benefit them."
Zoth's 30-year career spans from a variety roles with Ernst & Young, PepsiCo, Sodexho, and PSINet. Most recently, she served as CFO for MedImmune, a publicly traded biotechnology company, from 2004-07.
Upon exiting the corporate world, Zoth became an actively involved board member with several STEM-related companies. These companies include: Hyperion Therapeutics, a commercial-stage biopharmaceutical company committed to delivering life-changing treatments for orphan diseases; Aeras, a non-profit product development organization dedicated to the development of effective tuberculosis (TB) vaccines to prevent TB across all age groups in an affordable and sustainable manner; Orexigen Therapeutics, a biopharmaceutical company focused on the treatment of obesity; NewLink Genetics, a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutic products to improve treatment options for patients with cancer; and Circassia Pharmaceuticals, a specialty biopharmaceutical company focused on the development and commercialization of a range of allergy immunotherapy product candidates.
"It was an honor to have Lota Zoth speak to our STEM MBA students. Her background and experience in industries from healthcare to biotech gave our students a clear example of how business and the STEM fields can intersect," Mary Frances Weatherly, Director for the Rawls College's Graduate and Professional Programs, said. "Her outlook on how jobs will be emerging for students with a STEM and business background helps illustrate our STEM MBA students will have an advantage in the market place."
The speaker series occurs six times throughout the year and invites STEM graduates who have succeeded in business to speak to current students. The STEM MBA program, which launched in the summer of 2014, is a Master of Business Administration degree designed specifically for students with an undergraduate degree in a Science, Technology, Engineering or Mathematics discipline. For more information about the program, visit the STEM MBA website or contact Mary Frances Weatherly at email@example.com.This supports the efforts outlined in the Rawls College of Business Strategic Plan. Learn more about the LEADER 2020 Strategic Plan and follow our progress on Twitter at #RawlsLeads.